Prenetics Global (PRE) Non-Current Debt (2021 - 2023)
Prenetics Global's (PRE) quarterly Non-Current Debt came in at $680837.0 in Q4 2023, down 99.86% quarter-over-quarter from $486.4 million in Q4 2021.
Powered by 
Analysis
Prenetics Global (PRE) Non-Current Debt (2021 - 2023) Analysis & Trends
Prenetics Global (PRE) has reported Non-Current Debt for 2 consecutive years, with $680837.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $680837.0 in Q4 2023; TTM through Dec 2023 was $680837.0, a N/A change from a year earlier, with the FY2023 full-year figure at $680837.0, changed N/A from the prior year.
- Non-Current Debt was $680837.0 for Q4 2023 at Prenetics Global, down from $486.4 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $486.4 million in Q4 2021 and troughed at $680837.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 10.09 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 570.35 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 793.70 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 19.98 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 347.10 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 2.54 Bn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | - |